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Abstract
Cytokeratins are keratinous protein and assist cells to reduce mechanical stress 
on the intracytoplasmic layer of epithelial tissue. There are several unspecified 
mutations in the epithelial layer that may induces by environmental mutagens 
and pathogens. The unspecified mutations in the epithelium surface also disrupt 
biology of skin at multiple different levels and cause innate keratinizing disorders. 
These serve as a root generator of neurohormones and neuropeptides which mainly 
partake in the disruption. Generally, all 54 unique genes of human keratin partake 
in mutations and cause cutaneous tissue fragility, skin hypertrophic, and malignant 
transformation. In this chapter, unspecific factors that involved in the pathogen-
esis of skin diseases and the ways by which such keratin changes might harness to 
alleviate different skin conditions are also included. Consequently, the contribution 
of environmental changes in the frontier of mutations or misregulations of the 
cytokeratin genes, is also cited here.
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1. Introduction
Cytokeratin is an intermediate keratinous protein found in the intracytoplasmic 
cytoskeleton of epithelial tissue. Cytokeratin possess essential components for the 
epithelium layer with diameters of 6 nm (microfilaments) to 25 nm (microtubules). 
The microfilaments or microtubules support cells to resist mechanical stress [1–3]. 
In the 1970s, the term ‘cytokeratin’ was derived through the protein characterization 
in the intermediate filament [4]. Later, in 2006, with the new systemic nomencla-
ture, the terminology “cytokeratin” was termed as keratins. This nomenclature was 
under the nomenclature of the Human Genome Organization (HUGO) for both the 
gene and protein names [5, 6].
Keratin are the most complex protein in vertebrates and in filamentous form 
are essential epithelial cell structural stabilizers. That’s why; keratin is of unprec-
edented importance in genetics, embryology, pathology, and dermatology [7]. 
Keratin filaments are usually integrated with desmosomes and hemidesmosomes. 
They contribute: to the cohesion of the epithelial cells; for attachment of the base-
ment membrane; and for epithelial connectivity tissue transition [8, 9]. Although 
few keratin structures/skeletons also found as scattered or dispersed between 
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keratinous filaments in the cytoplasm of the internal parenchymatous organs. This 
behavior contributes to the (simple) unstratified epithelial membrane. These com-
ponent sprouts increase as tonofilaments and transformed into a cornified stratified 
epithelial sheet [10].
Although, Keratin are classified into alpha and beta keratins according to the 
amount of sulfur content and structure [11]. Alpha (α) keratin form epithelial 
layers in all vertebrates [12, 13]. Configurationally, alpha (α) keratin has abundant 
amounts of the hydrophobic amino acids: methionine, phenylalanine, valine, iso-
leucine, and alanine. Due to the occurrence of these amino acids, alpha (α) keratin is 
extraordinary for its strength, elasticity, tiredness, insolubility, and durability [14]. 
Apart from the diversity of the epithelial keratins (‘soft’ or ‘cyto’); hair and nails are 
built from a very distinct subfamily of ‘hard’ or ‘trichocytic keratins’ [10, 15–18]. 
Since they are enriched in stacked β pleated sheets and are known as corneous beta-
protein” or “keratin-associated beta-protein [19–20]. The epithelial keratins differ in 
their non-α-helical head and tail domain. This is due to the existence of high sulfur 
contents which is primarily responsible for the high filament linkage level of the 
keratin-associated protein [21, 22].
In filamentous form, keratin possesses a head-rod-tail structural arrangement 
with its basic polypeptide configuration consisting of a core alpha-helical coiled 
rod structure of about 310 amino acids in size. This central rod segment contains 
four helical structures interrupted by three short non-helical flexible reticulation/
Linker regions [9, 12, 23]. These linker or reticulation regions flank by the complex, 
non-helical amino-terminal head and carboxy-terminal tail domains. In the rod 
domain, a heptad repeat of amino acid residues is present. Furthermore, near 
the middle of the domain, the “stutter” region is found and is a highly conserved 
segment among IFs. This area does not take part in the development of coiled-coil 
heterodimers but plays specific roles in the extension and rotation characteristics 
of keratins [24, 25]. At the beginning and end of the heptad repeat regions in the 
rod domain; are the highly conserved helix initiation motif (HIP) and helix termi-
nation peptides (HTP). Respectively, HIP & HTP, both consist of 20 amino acid 
sequences related to different keratin gene families [26–28]. The heteropolymeric 
structure of type I and type II keratin collectively generate a filamentous form. 
These are all aligned laterally with a scalable and parallel overlap and form KIFs 
through lateral stacking and polymerization of chains [9, 29, 30].
In cytokeratins, all of the intermediate filament proteins have the template/
prototype structure that contains a central coiled-coil helix (310–350 amino acids). 
These are surrounded by the variable-length globular NH2-terminal head and 
COOH end-end tail domains [31–33]. Here, the keratin type I chain form a paired 
dimer with its type II counterpart and build an antiparallel fashion to a tetramer. 
Two tetramers transversely bind and resulted in a protofilament. Then, protofila-
ments are twisted into a keratin filament rope. Therefore, each keratin filament 
has a cross-section of 32 individual helical coils (Figure 1) [34–38]. The globular 
end-domains in most of the intermediate filament proteins contain all known sites 
for phosphorylation, glycosylation, and other relative activities [33, 39–42].
Usually, cytokeratin has an outstanding standard due to its high molecular diver-
sity. The molecular weight of human keratins ranges from 44 to 66 kDa. In human, 
all 54 distinct functional keratin genes are found on chromosomes 12 & 17 and 
represent the typical intermediate filament category of epithelial cells. All keratin 
filaments are specifically bundled as tonofilaments in some but not all endothelium 
[43, 44]. In humans, all 54 distinct functional keratin genes are characterized as 
keratin type- I genes (17 epithelial and 11 hair keratin genes) and keratin type- II 
genes (20 epithelial keratins and 6 hair keratins) (Figure 2) [45, 46]. Type I 
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keratin comprises the KRT9–KRT10, KRT12–KRT28, and KRT31–KRT40 (includ-
ing KRT33a and KRT33b) genes, while type II keratin has KRT1–KRT8 (including 
KRT6a, KRT6b, and KRT6c) and KRT71–KRT86. Besides, the “stratified keratins” 
comprise KRT1 to KRT6 and KRT10 to KRT17 [10, 47–51].
Figure 1. 
Differentiated Keratinocytes in Structure of Human Skin.
Figure 2. 
Ideogram and Phylogenetic description of Mammalian Keratin Chromosome (i.e. 12 & 17).
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The human skin is the largest of the epithelial layers of the body and has a crucial 
strategic defensive position at the boundary between the interior and exterior envi-
ronment of the body. Histologically, the skin is made of multi-layered, non-vascular, 
stratified epidermal squamous tissues which are extending to dense fibrous con-
nective dermal tissues [52, 53]. For each cytoskeleton of the epithelial layer, there 
are three abundant filament systems available: actin-microfilament systems (MFs; 
7–10 nm diameter; IFs; 10–12 nm diameter), interlinked microtubules, and (MTs; 
diameter 25 nm). Each filament system comprises a corresponding gene family 
with specially regulated cell-tissue regulators that encode each protein family [54]. 
Mutations in any cutaneous-associated keratin genes are increasingly apparent, 
which causes a host of hereditary skin disorders; and specified to weakened cell 
tissue integrity & damaged the skin [42, 55–57].
The regional specificity of keratin expression may add to the intrinsic special-
ization of regional keratinocyte stem cells. Disorders in keratin may be genetic 
or acquired. Several keratin mutations have been identified as a cause for many 
diseases in the skin and mucosal tissues [26, 58–60]. Beyond the biological roles, 
keratin expression describes cells not only as “epithelial,” but as distinctive even for 
characterize stages of cellular epithelial differentiation from embryonic to adult or 
internal maturation programs throughout growth. [10, 61, 62].
Mutations in the keratin amino acid sequence significantly affect the montage 
of keratin filaments [63–65]. Keratin genes repeat along with frameshift mutation 
and generate the pseudogenes. Approximately 87% of individuals’ keratin pseu-
dogenes are equivalent to keratin genes 8 & 18 [66]. keratin pseudogenes continu-
ously exchange their position on multiple chromosomes through crossing-overs or 
translocations [45, 67]. Mutations of keratin genes contribute to several human and 
murine skin disorders [68].
Keratinous genetic mutations cause various keratin disorders known as 
“Keratinopathies”. In the last decades, the spectrum of skin disorders has been 
increased enormously due to the abnormal function of structural proteins 
(keratins, filaggrin, loricrin, cornified cell envelope, etc.) [26, 47, 69–73]. It 
has also boost up or affected by deficient enzymes or transport proteins that 
are essential for lipid metabolism in the epidermis (cholesterol sulphatase, 
lipoxygenases, ABCA12, etc.). Mutations in epidermal keratins cause several 
skin diseases like congenital ichthyosis, epidermolytic ichthyosis, congenital 
bullous disease, corneal dystrophy, erythroderma, and pachyonychia congenital 
[74–76]. All the above diseases are due to mutation in the corneal keratin genes 
(KRT3, KRT12); mutation in simple epithelial keratin genes (KRT8/18, KRT19, 
KRT9); mutations in epithelial keratin genes (KRT6A, KRT6B, KRT6C, KRT16 
or KRT17); mutations inKRT1 or KRT10 or basal layer keratinocytes genes 
(KRT5&KRT14) [77, 78].
In the epidermis and associated skin appendages, mutagenic cutaneous disor-
ders are commonly termed as genodermatoses [79]. Keratin mutations represent 
keratin-related disorders including epidermolysis Bullosa Simplex (Keratin 
gene 5& 14), Keratinopathic Ichthyosis (Keratin gene l, 2 &10), Palmoplantar 
Keratoderma (Keratin gene 9), Pachyonychia Congenital (Keratin gene 6a,6b1,16 
&17), and Monilethrix (Keratin gene 81, 83 & 86), etc. [18, 26, 80–82].
Epidermolysis bullosa is one of hereditary keratin disorder specified as 
mechanic-blistered skin. Epidermolysis bullosa is caused by desmoplakin or 
plakophilin type mutations in keratin genes KRT5 and KRT14 [83, 84]. In the 
manifestation of Epidermolysis bullosa, skin fragility reveals and can be increased 
in fluid-filled blister form or by the erosion of the skin. It causes failure in kera-
tinization and affects the integrity or the ability of the skin to resist mechanical 
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stresses. Hence, disease signs may extend for esophageal contraction, squamous 
carcinoma [85].
Epidermolysis Bullosa possess four main types: Epidermolysis Bullosa Simplex 
(EBS), Dystrophic Epidermolysis Bullosa (DEB), Junctional Epidermolysis Bullosa 
(JEB), and Kindler Syndrome (KS). In Epidermolysis Bullosa, all above disorders 
are inherited keratin disorder caused by mutations in Keratin genes 5 & 14 and 
plectin [86, 87]. The mutations in the gene of plectin are associated with mus-
cular dystrophy. Symptomatically, Suprabasal epidermolysis causes fragility and 
blistering of skin or erosion by minor injury or friction (Rubbing or Scratching). 
Blistering may extend to mucous of the mouth with digestive tract and directly 
can affect the digestive system. Because of this, many infected children are poorly 
nourished and grow variably. The extended blistering cause irregular red patches 
of granulation sheath and rise to bleed regularly. In the enlargement of the disease, 
newborns lose essential metabolic nutriment and fluids. Consequently, granular 
sheath affects the respiratory tract and difficult to speaking and breathing [88, 89]. 
Besides, Kindler syndrome is a type of epidermolysis bullosa and causes skin blis-
tering but often on the hands and feet. It generates scarring on the skin between the 
fingers and between the toes. Kindler syndrome is genetic dermatitis even though 
may also cause by ultraviolet (UV) rays and sunburn undoubtedly. The Kindler 
syndrome can expand on the outward of the oral cavity, throat, intestines, genitals, 
and urinary regions. Ultimately, the condition might be converted into squamous 
follicle melanoma [90–93].
Keratinopathic ichthyosis is a generative disorder in the human that occurs by a 
mutation in Keratin genes (KRT1, KRT2, and KRT10). It exhibits anomalies in the mem-
branous filaments and develops the spectrum of clinical manifestations [26, 94, 95]. 
Therefore, it is also known as superficial keratin keratodermas [60, 96]. This disorder 
manifests symptoms as scratched skin fragility, blister generation over flexural areas on 
erythroderma, and thick stratum corneum. The blistering and erythema in Neonates 
appear by birth though over time manifestation increases. Usually, Palmoplantar 
keratoderma also appears with Keratinopathic ichthyosis. It exhibits the thickening of 
the palm’s skin of the hands and soles of the feet [26, 97, 98].
Monilethrix is a pervasive innate disorder. It occurs due to mutation in the 
human keratin gene KRT86 and KRT81 [99–100]. Clinically, Monilethrix is distin-
guished by dystrophic hair reduced region or with complete alopecia. Hair shaft 
deformation is defined by elliptical nodes that are commonly separated by reduc-
tions in skin color, by the appearance of scars, scratches, or rashes at the constricted 
regions [101, 102]. Infected hair also exhibits scarcities in the cortex of the skeletal 
hair shaft proteins, especially for trichocyte keratins. Rarely, hair possesses 
regrowth through adolescence or pregnancy [103, 104].
Pseudofolliculitis Barbae (PFB) and loose anagen hair syndrome (LAHS) are 
other hair disorders due to mutation in the keratin gene KRT75. Certain gene is 
located in the form of a cluster on the long arm of chromosome twelve. It originates 
with the follicular infection on the neck and beard region of the face [105–108]. 
Sometimes disease also expands due to shaving on surrounding ingrown facial 
hairs, on the body wherever hair is shaved or plucked, including axilla, pubic 
area, and legs [18]. Apart from the cutaneous layer, nail dysplasias (Pachyonychia 
congenital) also take place in the hypertrophic portion of nails. It occurs due to 
mutation in the genes KRT6a, KRT16, and KRT107 [109, 110].
Ectodermal dysplasia is a separate one disorder similar to keratoderma or 
ichthyosis. It is associated with skin appendages bearing with the hair, nails, and 
sweat glands. Normally, this disorder is caused by a mutation in the KRT85  
gene [111, 112].
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2. Contribution of environmental constituents in mutation
Throughout the world, skin melanoma is the 19th most widespread cancer. 
Usually, almost all types of skin cancers are related to environmental factors 
including contact with immense ultraviolet radiation or due to sun exposure. 
Environmental mutagens may be synthetic or natural agents in nature  
[74, 113–116]. these mutagens produce genetic mutations or expand mutational 
activities during the life span [117, 118]. Most of the environmental mutagens 
possess genotoxic effects on the next generation via germ cells and continue in 
the inherent form.
Besides ultraviolet radiation, other radioactive, heavy metals, organic solvents 
or chemicals, viruses, bacteria, etc. also perform a role to cause cell damage 
[119–122]. Even, consumption of cigarette smoke, dietary contaminants including 
mycotoxin, aflatoxin B1, fat consumption, and unorganized stress are themselves 
integral environmental factors that contribute to cytokeratin disruptions [123]. 
All these agents are come in contact with the human through directly via skin & 
lungs or by ingestion. From this channel, these circulate in the body (blood, lymph 
glands, muscles, bones, tissues, and organs) and initiate mutations. In mutagen-
esis, these all mutagens penetrate directly to cellular and nuclear membranes and 
damage DNA by cross-linking (chemically gluing) two bases together. Sometimes, 
Mutagenesis is also caused by aberrant DNA methylation (epigenetic change) at the 
genomic level and post-translational modifications at the protein level. Finally, this 
results in genetic deficiencies cause.
3. Conclusion
Cytokeratins are essential protectors of epithelial structure found in the 
intracytoplasmic cytoskeleton of epithelial tissue. The occurrence of mutation in 
cytokeratin genes generates several genetic dermal disorders. In this genetic altera-
tion, several environmental factors (ultraviolet, reactive oxygen species (ROS), 
deaminating agents, polycyclic aromatic hydrocarbon (PAH), ethylnitrosourea, 
azide, dyes, and heavy metals) take place as mutagen factors. The present chapter 
conclusively stated different cytokeratins disorders caused by environmental 
mutagens, i.e., synthetic or natural mutagens. In the end, based on environmental 
mutagens contributions, it can be stated that the genetic and epigenetic effects, 
arise/enhance through environmental mutagens/carcinogens, are the subject of 
innovative research.
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